当前位置:循环首页正文Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-..
Lancet. 2003 Sep 6;362(9386):767-71. McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA; CHARM Investigators and Committees. University of..
Am Heart J. 2003 Jun;145(6):1030-5. Jorgensen B, Thaulow E; Coronary Angioplasty Amlodipine Restenosis Study. Department of Cardiology, Rikshospitalet, University of Oslo, Oslo, Norway. bj-jorge..
Am J Cardiol. 2002 Nov 15;90(10):1107-12. Malmqvist K, Kahan T, Edner M, Bergfeldt L. Division of Internal Medicine, Section of Cardiology, Karolinska Institutet Danderyd Hospital, S-182 88 Sto..
Hypertension. 2005;45:240.Masahiro Kikuya; Takayoshi Ohkubo; Kei Asayama; Hirohito Metoki; Taku Obara; Shin Saito; Junichiro Hashimoto; Kazuhito Totsune; Haruhisa Hoshi; Hiroshi Satoh; Yutaka Imai Fro..
JAMA. 2004 Nov 3;292(17):2096-104.Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, Greenbaum AB, Berger PB, Cannon CP, Cohen DJ, Gibson CM, Saucedo JF, Kleiman NS, Hochman JS..
JAMA. 2005;293:427-435. The CREATE Trial Group Investigators Context: Although reperfusion therapy, aspirin, -blockers, and angiotensin-converting enzyme inhibitors reduce mortality when used earl..
JAMA. 2005;293:437-446. The CREATE-ECLA Trial Group Investigators Context: Glucose-insulin-potassium (GIK) infusion is a widely applicable, low-cost therapy that has been postulated to improve morta..
N Engl J Med 2005; 352: 341-350 Solomon Tesfaye, M.D., Nish Chaturvedi, M.D., Simon E.M. Eaton, D.M., John D. Ward, M.D., Christos Manes, M.D., Constantin Ionescu-Tirgoviste, M.D., Daniel ..
Am Heart J 2005;149(1):104-111 Monica Franciosi a, Fabio Pellegrini a, Giorgia De Berardis a, Maurizio Belfiglio a, Barbara Di Nardo a, Sheldon Greenfield b, Sherrie H. Kaplan b, Maria C. E..
Lancet. 2004 Aug; 364(9435):685-696. Colhoun HM, Betteridge DJ, Durrington PN, et al; CARDS investigators. INTERPRETATION: Atorvastatin 10 mg daily is safe and efficacious in reducing the risk of f..
JAMA. 2004;292(18):2227-2236. Context β-Blockers have been shown to decrease cardiovascular risk in patients with hypertension and type 2 diabetes mellitus (DM); however, some components of the m..
Context β-Blockers have been shown to decrease cardiovascular risk in patients with hypertension and type 2 diabetes mellitus (DM); however, some components of the metabolic syndrome are worsened by..
Björn Dahlöf, Peter S Sever, Neil R Poulter, Hans Wedel, D Gareth Beevers, Mark Caulfield, Rory Collins, Sverre E Kjeldsen, Arni Kristinsson,Gordon T McInnes, Jesper Mehlsen, Markku Niemi..
目的:FEVER研究是一项双盲、安慰剂对照的随机化临床研究,高危心血管风险的高血压患者在整个试验过程中接受小剂量利尿剂双氢克尿噻(HCTZ)治疗,在血压已降低后,比较在此基础上加小剂量CCB非洛地平或安慰剂对心血..